Azioni LexaGene Holdings Inc. Toronto S.E.
Azioni
LXG.H
CA52886L1031
Biotecnologia
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Variaz. 1 gen. | Capi. | |
---|---|---|
-37,33% | 8,55 Mrd | |
+14,86% | 3,8 Mrd | |
+7,38% | 2,44 Mrd | |
-25,96% | 1,87 Mrd | |
-17,30% | 1,74 Mrd | |
+36,49% | 1,19 Mrd | |
+32,58% | 830 Mln | |
-7,64% | 711 Mln | |
-18,37% | 589 Mln |